250 P125 Pill - blue capsule/oblong
Pill with imprint 250 P125 is Blue, Capsule/Oblong and has been identified as Cefuroxime Axetil 250 mg. It is supplied by Orchid Healthcare.
Cefuroxime is used in the treatment of Bladder Infection; Bacterial Infection; Bronchitis; Bone infection; Sepsis and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Cefuroxime 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 250 P125
Cefuroxime Axetil
- Imprint
- 250 P125
- Strength
- 250 mg
- Color
- Blue
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Second generation cephalosporins
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Orchid Healthcare
- Inactive Ingredients
-
corn starch,
croscarmellose sodium,
sodium lauryl sulfate,
microcrystalline cellulose,
silicon dioxide,
hypromelloses,
titanium dioxide,
propylene glycol,
FD&C Blue No. 1,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 16714-0232 (Discontinued) | NorthStar Rx LLC |
| 42043-0230 (Discontinued) | Karalex Pharma |
Related images for "250 P125"
More about cefuroxime
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (153)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: second generation cephalosporins
- Breastfeeding
- En español
Patient resources
- Cefuroxime oral/injection drug information
- Cefuroxime (Injection, Intravenous) (Advanced Reading)
- Cefuroxime (Oral) (Advanced Reading)
- Cefuroxime Tablets
- Cefuroxime Injection
- Cefuroxime Oral Suspension
Other brands
Professional resources
- Cefuroxime monograph
- Cefuroxime Axetil (FDA)
- Cefuroxime Axetil Oral Suspension (FDA)
- Cefuroxime Dextrose (FDA)
- Cefuroxime Injection (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
